| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University California, Davis, CA
Canine histiocytic proliferative disorders include a wide spectrum of diseases characterized by different biologic behaviors. The etiology and pathogenesis of these diseases are largely unknown. The clinicopathologic, morphologic and immunophenotypic characteristics of canine localized and disseminated histiocytic sarcoma were examined in 39 dogs. Rottweilers, Bernese Mountain Dogs, and retrievers were most commonly affected (79%). Localized histiocytic sarcomas (19 dogs) arose from a single site, and metastatic lesions were observed in draining lymph nodes. Predilection sites were subcutis and underlying tissues on extremities, but tumors occurred in other locations, including spleen, lung, brain, nasal cavity, and bone marrow. Disseminated histiocytic sarcomas (20 dogs), a multisystem disease previously described as malignant histiocytosis, primarily affected spleen, lungs, bone marrow, liver, and lymph nodes. Both localized and disseminated canine histiocytic sarcomas were composed of pleomorphic tumor cell populations. CD1+, CD4-, CD11c+, CD11d-, MHC II+, ICAM-1+, Thy-1± tumor cells were identified in all snap-frozen samples (31 dogs). This phenotype is characteristic for myeloid dendritic antigen-presenting cell lineage. Hence, canine localized and disseminated histiocytic sarcomas are likely myeloid dendritic cell sarcomas. Dendritic antigen-presenting cells are a heterogeneous cell population with regards to their ontogeny, phenotype, function, and localization. The exact sublineage of the proliferating dendritic antigen-presenting cells involved in canine histiocytic sarcomas remains to be determined. Phenotypic analysis of formalin-fixed tissues from eight dogs was limited by available markers. Morphologic features and the phenotype CD18+, CD3-, and CD79a- were the most useful criteria to indicate likely histiocytic origin.
Key words: CD1; CD11c; dendritic antigen-presenting cells; dogs; histiocytic sarcoma; histopathology; ICAM-1; immunohistochermistry; malignant histiocytosis; MHC II.
Request reprints from Dr. K. Affolter, VM-PMI, School of Veterinary Medicine, University of California, Davis, CA 95616 (USA). E-mail: vkaffolter{at}ucdavis.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Abadie, B. Hedan, E. Cadieu, C. De Brito, P. Devauchelle, C. Bourgain, H. G. Parker, A. Vaysse, P. Margaritte-Jeannin, F. Galibert, et al. Epidemiology, Pathology, and Genetics of Histiocytic Sarcoma in the Bernese Mountain Dog Breed J. Hered., July 1, 2009; 100(suppl_1): S19 - S27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Molenaar, A. C. Breed, E. J. Flach, I. A. P. McCandlish, A. M. Pocknell, T. Strike, A. Routh, M. Taema, and B. A. Summers Brain tumours in two Bactrian camels: a histiocytic sarcoma and a meningioma Vet Rec., May 30, 2009; 164(22): 684 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Avallone, P. Helmbold, M. Caniatti, D. Stefanello, R. C. Nayak, and P. Roccabianca The Spectrum of Canine Cutaneous Perivascular Wall Tumors: Morphologic, Phenotypic and Clinical Characterization Vet. Pathol., September 1, 2007; 44(5): 607 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Soller, H. M. Escobar, S. Willenbrock, M. Janssen, N. Eberle, J. Bullerdiek, and I. Nolte Comparison of the Human and Canine Cytokines IL-1({alpha}/{beta}) and TNF-{alpha} to Orthologous Other Mammalians J. Hered., August 3, 2007; (2007) esm025v3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pinard, C. R. Wagg, C. Girard, M. Kiupel, and C. Bedard Histiocytic sarcoma in the tarsus of a cat. Vet. Pathol., November 1, 2006; 43(6): 1014 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Moore, V. K. Affolter, and W. Vernau Canine Hemophagocytic Histiocytic Sarcoma: A Proliferative Disorder of CD11d+ Macrophages. Vet. Pathol., September 1, 2006; 43(5): 632 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Affolter and P. F. Moore Feline progressive histiocytosis. Vet. Pathol., September 1, 2006; 43(5): 646 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Nambiar, S. R. Boutin, R. Raja, and D. W. Rosenberg Global Gene Expression Profiling: A Complement to Conventional Histopathologic Analysis of Neoplasia Vet. Pathol., November 1, 2005; 42(6): 735 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Fernandez, K. H. West, M. L. Jackson, and B. A. Kidney Immunohistochemical and Histochemical Stains for Differentiating Canine Cutaneous Round Cell Tumors Vet. Pathol., July 1, 2005; 42(4): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Fry, W. Vernau, P. A. Pesavento, C. Bromel, and P. F. Moore Hepatosplenic Lymphoma in a Dog Vet. Pathol., September 1, 2003; 40(5): 556 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lacroix-Triki, L. Lacoste-Collin, S. Jozan, J.-P. Charlet, C. Caratero, and M. Courtade Histiocytic Sarcoma in C57BL/6J Female Mice is Associated with Liver Hematopoiesis: Review of 41 Cases Toxicol Pathol, April 1, 2003; 31(3): 304 - 309. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
